In this episode, David talks with Victor Acero, co-founder of the psychedelic conference PhilaDelic, to learn about the conference and about the different topics that are expected to be covered by guest speakers during it such as consciousness and mind, law and public policy, and spiritualism, mysticism, and theology, to name a few.
Similar Posts
5 Ways ‘The Matrix Resurrections’ Is More Psychedelic Than the Original Trilogy
“The Matrix” was always an allegory for awakening to your…
Will MAPS IPO? The FIRST American Psychedelic ETF (PSY), New LSD Studies & More
There were LOTS of general news important for the psychedelic industry as a whole and very important study results that will influence some of our favorite stocks such as MindMed (MMED / MNMD / MMQ) and Compass Pathways (CMPS)!
In today’s episode we’ll cover a new American psychedelic ETF which is hitting the market under ticker symbol PSY, some new psilocybin and LSD studies, whether MAPS will turn into a public company and some updates on the California and New York bills we have been covering for a while now.
Enjoy the episode!
Timestamps:
0:00 – Intro
0:40 – The First American Psychedelic ETF (PSY)
5:50 – MAPS Considering An IPO?
12:28 – Psilocybin Assisted-Therapy Is 4-Times More Effective Than Typical SSRIs
15:29 – New Study On How LSD Affects The Brain
21:08 – The California Senate Has Approved a Bill To Legalize the Possession Of Psychedelics Like Psilocybin And LSD
23:00 – New York Bill Proposes State-Sponsored Psychedelic Research Institute
Links:
New Psychedelic ETF (NYSE : PSY) :
https://www.defianceetfs.com/psy/
https://psychedelicspotlight.com/psy-first-u-s-psychedelic-etf/
Maps Considering An IPO?:
https://www.reddit.com/r/shroomstocks/comments/nqoy0z/maps_considering_ipo/
https://youtu.be/v2HycPpjf6Y
Study Shows Psilocybin Assisted-Therapy Is 4-Times More Effective Than Typical Antidepressants:
https://thedalesreport.com/psychedelics/study-shows-psilocybin-assisted-therapy-4-times-more-effective-than-typical-antidepressants/
New Study On How LSD Affects The Brain:
https://www.theguardian.com/science/2021/may/19/acid-test-scientists-show-how-lsd-opens-doors-of-perception
The California Senate Has Approved a Bill To Legalize the Possession Of Psychedelics Like Psilocybin And LSD:
https://www.marijuanamoment.net/california-senate-approves-bill-to-legalize-possession-of-psychedelics-like-psilocybin-and-lsd/
New York Bill Proposes State-Sponsored Psychedelic Research Institute:
https://psychedelicspotlight.com/new-york-bill-psychedelic-research-institute/
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
Video editing: @themyaholy
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#MindMed #PsychedelicStocks #MAPS
MindMed’s New PATENT ( MNMD/ MMED)
Today we are going to be talking about MindMed’s, (MNDM : NASDAQ), (MMED : NEO) patent application made in collaboration with BioXcel Therapeutics.
BioXcel is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology.
The Patent is “for detecting and preventing the early onset of agitation in patients predisposed to highly agitated behaviour”.
Enjoy the episode!
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Music from:
www.bensound.com
Video editing: @themyaholy
Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#mindmed #mmed #mnmdstock
How To Reduce Anxiety and Depression By Fixing Nervous System Dysregulation
The good news is that if we can get the nervous system unstuck, we’ll stop feeling so anxious and depressed. Thankfully, there are some fantastic tools for fixing nervous system dysregulation.
Creating Inclusive KAP Training Practices with TRIPP Founder Jennifer Montjoy
In this episode, Swati Sharma sits down with Jennifer Montjoy, Founder of Transpersonal Research Institute of Psychotherapeutic Psychedelics also known as TRIPP.